Description: Hvsen Biotechnology Co., Ltd. engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally. Its products include tylvalosin raw materials, various tylvalosin preparations, florfenicol preparations, and other macrolides products. The company produces various veterinary drug products of raw materials and preparations, as well as traditional Chinese medicines extractives. Hvsen Biotechnology Co., Ltd. is based in Wuhan, China.
Home Page: www.whhsyy.com
No.208 Zhangbai Road
Wuhan,
430042
China
Phone:
86 27 8323 5399
Officers
| Name | Title |
|---|---|
| Mr. Kaijie Yang | Financial Director, Deputy GM, Chief Financial Officer & Sec. |
| Ms. Jian Zhou | Director of HR |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 86.2083 |
| Price-to-Book MRQ: | 2.3513 |
| Price-to-Sales TTM: | 3.9361 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 828 |